ARSENAL SET TO OPEN NEW CONTRACT TALKS WITH SAKA. (PHOTO).

Image
 Arsenal set to open new contract talks with Saka Arsenal are set to open formal talks with Bukayo Saka over a new contract as the forward enters the final two years of his current deal. Saka has been unavailable since December after sustaining a serious hamstring tear in the victory over Crystal Palace at Selhurst Park - an injury that eventually required surgery. But his importance to Mikel Arteta's team remains unquestioned with the club preparing to meet the player's representatives over a contract extension.Arsenal want to avoid any uncertainty regarding their star player's future and will make securing Saka to a longer contract one of their top priorities. The 23-year-old England international signed his current contract - understood to be worth a minimum of Ā£10m per season - in 2022. But that contract is due to expire at the end of the 2026-27 season with early moves towards opening concrete talks already initiated. The process is expected to accelerate in the not to...

GENE THERAPY OFFERS NEW SICKLE CELL CURE IN THE U. S. (PHOTO).


 Gene Therapy Offers New Sickle Cell Cure in the US


Sebastien Beauzile, a 21-year-old from Laurelton, Long Island, has become the first person in New York State to be cured of sickle cell anemia using the groundbreaking Lyfgenia gene therapy.


Administered at Cohen Childrenā€™s Medical Center, this innovative treatment provides hope for many suffering from the painful genetic disorder, Forbes reported on Sunday.


A Lifelong Battle

Sickle cell anemia causes abnormally shaped red blood cells, leading to severe pain and potential organ damage. Beauzile, diagnosed at just four months old, endured frequent hospitalizations due to intense pain crises, which he described as ā€œ10 out of 10ā€ in severity.


Gene Therapy Breakthrough

Developed by Bluebird Bio and approved by the FDA in December 2023, Lyfgenia works by extracting a patientā€™s blood stem cells, genetically modifying them to include functional hemoglobin genes, and reinfusing them into the bloodstream. This cutting-edge approach marks a major step forward in treating sickle cell disease.

Comments

Popular posts from this blog

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

ACTOR BABA IJESHA APPEALS FIVE-YEAR JAIL SENTENCE FOR SEXUAL ASSAULT. (PHOTO).